Sign in to view content

Dual Targeting VEGF/Ang3 Surrobody in an Experimental Model of Neovascularization

Jeffrey L. Olson, MD

Video
Published 2019

Jeffrey Olson, MD

Related

Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema
Victor Hugo Gonzalez, MD
Updates from the Field
2024
Diabetic Retinopathy Take Home Panel
Annual Meeting Talks
2020
Intravitreal Injections: Logistics, Safety, and Pearls
Andrew A. Moshfeghi, MD, MBA, FASRS
Webinars and Journal Clubs
2018

Category: AMD-Neovascular

See more